The American Journal of Medicine
Volume 124, Issue 11 , Pages 997-999, November 2011
]
O trabalho acima publicado na The American Journal of Medicine (IF 5.115) não desmerece a atuação do CD em pacientes com doenças cardíacas. Frequentemente vejo afirmações apaixonadas sobre determinado assunto e quanto mais estudo e aprendo ao longo desses anos, mais difícil fica fazer afirmações categóricas sobre qualquer assunto.
", we await randomized intervention trials that establish whether treatment of PD diminishes the risk of primary or secondary CVD events. As we move toward the root of the problem, a complete understanding of the relationship between PD and CVD will require not only a recognition of systemic inflammation as a shared process, but attention to the health behaviors that may be common to both entities."
Prashant Vaishnava, MD
Rajeev Narayan, MD
Valentin Fuster, MD, PhD
The Zena and Michael A. Wiener Cardiovascular Institute
The Mount Sinai Medical Center New York, NY
National Center for Cardiovascular Research (CNIC) Madrid, Spain
